Home >
Medicine Info >
Trajenta Duo 2.5 mg/ 850 mg Tablet
Loading interface...

Trajenta Duo 2.5 mg/ 850 mg Tablet

Manufactured byBoehringer Ingelheim India Pvt. Ltd.
ContainsMetformin (850 mg) + Linagliptin (2.5 mg)
Description
Trajenta Duo 2.5 mg/ 850 mg Tablet is a combination medicine used for the treatment of type 2 diabetes mellitus. Patients are advised to maintain a strict exercise and diet regimen along with this medicine to get the best possible effect. This medicine is not recommended for use in patients below 18 years of age.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Trajenta Duo 2.5 mg/ 850 mg Tablet

  • Anxiety
  • Blurred vision
  • Confusion
  • Dizziness
  • Nausea
  • Slurred speech
  • Unusual tiredness or weakness
  • Diarrhea
  • Heartburn
  • Sore throat

Uses of Trajenta Duo 2.5 mg/ 850 mg Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1-3 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to linagliptin, any other dipeptidyl peptidase 4 inhibitors, metformin, any other biguanides, or any other inactive ingredients present along with these medicines.

Severe kidney impairment

This medicine is not recommended for use in patients with a severe impairment of kidney function due to the increased risk of serious adverse effects.

Metabolic Acidosis

This medicine is not recommended for use in patients with a known history of metabolic acidosis due to the increased risk of worsening of the patient's condition.

Type 1 Diabetes mellitus

This medicine is not recommended for use in patients with type 1 diabetes mellitus since it is not effective in treating this condition.

Diabetic ketoacidosis

This medicine is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.
General warnings

Bullous pemphigoid

This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Arthralgia

This medicine should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient's condition. Close monitoring of patient's condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in pediatrics

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Lactic Acidosis

This medicine may cause lactic acidosis, which may be fatal, in some patients. This risk is especially higher in patients suffering from heart diseases, kidney diseases, etc. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures and replacement with a suitable alternative may be required based on the clinical condition.

Alcohol use

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious adverse effects.

Type I diabetes

This medicine is not recommended for use in patients suffering from Type I diabetes since it is not effective in treating such patients.

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments may be required in some cases.

Kidney diseases

This medicine should be used with caution in patients with a known history of kidney diseases due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Stress

Use of this medicine should be discontinued in patients exposed to stressful conditions such as a fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor's supervision.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Aripiprazole

Clozapine

Gatifloxacin

Iodinated Contrast Media

Aloe Vera

Dexamethasone

Dopamine

Acetazolamide

Bexarotene

Disease interactions

Pancreatitis

This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Lactic Acidosis

This medicine may cause lactic acidosis in some patients. This risk is especially higher in patients with kidney diseases, heart diseases, or septicemia. Close monitoring of blood glucose levels, kidney function, heart function, and liver function may be required for such patients based on the clinical condition. Report any symptoms such as fatigue, breathing difficulty, increased sleep, nausea, vomiting, diarrhea, irregular heartbeat, etc. to the doctor immediately. Appropriate corrective measures and discontinuation of therapy may be required in some cases based on the clinical condition.

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments might be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine as prescribed by the doctor. It is advised to take this medicine with meals. Your dose is likely to change over time based on the therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. Do not change the dose or duration of use without consulting your doctor. Consult the doctor if you experience any undesirable side effects.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
Metformin decreases absorption of glucose from the intestines and increases the action of insulin in the body. Linagliptin increases insulin and lowers glucagon production. The combination is thus better effective than monotherapy in lowering the blood glucose levels.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Antidiabetic combinations

Schedule

Schedule H

The Pharmaceutical Journal [Internet]. 2017 [cited 22 December 2017]. Available from:

https://www.old.health.gov.il/units/pharmacy/trufot/alonim/Rishum_2_273846916.pdf

[Internet]. 2017 [cited 22 December 2017]. Available from:

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002279/WC500130969.pdf

TGA eBS - Product and Consumer Medicine Information Licence [Internet]. Ebs.tga.gov.au. 2017 [cited 22 December 2017]. Available from:

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01330-1&d=2017122216114622483

[Internet]. 2017 [cited 22 December 2017]. Available from:

https://www.boehringer-ingelheim.ca/sites/ca/files/documents/jentaduetocien_0.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 May 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.